Organon Sweden AB
- B01 - Agentes antitrombóticos
- LIXIANA film-coated tablet 15 mg
- LIXIANA film-coated tablet 30 mg
- LIXIANA film-coated tablet 60 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- RENITEC COMP. tablet 20 mg+12.5 mg
- RENITEC tablet 10 mg
- RENITEC tablet 2.5 mg
- RENITEC tablet 20 mg
- RENITEC tablet 5 mg
- C10 - Agentes modificadores de los lípidos
- EZETROL tablet 10 mg
- INEGY tablet 10 mg+10 mg
- INEGY tablet 10 mg+20 mg
- INEGY tablet 10 mg+40 mg
- INEGY tablet 10 mg+80 mg
- D07 - Preparados dermatológicos con corticosteroides
- DIPROSALIC cutaneous solution 0.5 mg/g+20 mg/g
- DIPROSALIC ointment 0.5 mg/g+30 mg/g
- ELOCON cream 0.1%
- ELOCON cutaneous solution 0.1%
- ELOCON ointment 0.1%
- G02 - Otros preparados ginecológicos
- NUVARING vaginal delivery system 0.120 mg/24 h+0.015 mg/24 h
- G03 - Hormonas sexuales y moduladores del sistema genital
- CERAZETTE film-coated tablet 75 µg
- DESOLETT 28 tablet 30 µg+150 µg
- DESOLETT tablet 30 µg+150 µg
- ELONVA I FÖRFYLLD SPRUTA solution for injection 100 µg/0.5 ml
- ELONVA I FÖRFYLLD SPRUTA solution for injection 150 µg/0.5 ml
- EXLUTENA tablet 0.5 mg
- LUEVA film-coated tablet 75 µg
- MERCILON 28 tablet 0.15 mg+0.02 mg
- NEXPLANON implant 68 mg
- PUREGON solution for injection 150 IU/0.18 ml
- PUREGON solution for injection 300 IU/0.36 ml
- PUREGON solution for injection 600 IU/0.72 ml
- PUREGON solution for injection 900 IU/1.08 ml
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- ORGALUTRAN solution for injection 0.25 mg/0.5 ml
- H02 - Corticosteroides para uso sistémico
- CELESTON BIFAS suspension for injection 11.4 mg/2 ml
- CELESTON BIFAS suspension for injection 28.5 mg/5 ml
- CELESTON BIFAS suspension for injection 5.7 mg/1 ml
- L01 - Antineoplásicos
- ONTRUZANT powder for solution for infusion 150 mg
- ONTRUZANT powder for solution for infusion 420 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- ADROVANCE tablet 70 mg+2 800 IU
- ADROVANCE tablet 70 mg+5 600 IU
- FOSAVANCE tablet 70 mg+2 800 IU
- FOSAVANCE tablet 70 mg+5 600 IU
- VANTAVO tablet 70 mg+2 800 IU
- VANTAVO tablet 70 mg+5 600 IU
- N03 - Antiepilépticos
- TALOXA oral suspension 120 mg/ml
- TALOXA tablet 600 mg
- N04 - Antiparkinsonianos
- SINEMET tablet 12.5 mg+50 mg
- SINEMET tablet 25 mg+100 mg
- N05 - Psicolépticos
- SYCREST sublingual tablet 10 mg
- SYCREST sublingual tablet 5 mg
- N06 - Psicoanalépticos
- REMERON-S orodispersible tablet 15 mg
- REMERON-S orodispersible tablet 30 mg
- REMERON-S orodispersible tablet 45 mg
- R01 - Preparaciones nasales
- AERINAZE modified-release tablet 2.5 mg+120 mg
- NASONEX nasal spray, suspension 50 µg/dose
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- SINGULAIR chewable tablet 4 mg
- SINGULAIR chewable tablet 5 mg
- SINGULAIR film-coated tablet 10 mg
- SINGULAIR granules 4 mg
- R06 - Antihistamínicos para uso sistémico
- AERIUS film-coated tablet 5 mg
- AERIUS oral solution 0.5 mg/ml
- AERIUS orodispersible tablet 2.5 mg
- AERIUS orodispersible tablet 5 mg
- AZOMYR film-coated tablet 5 mg
- AZOMYR oral solution 0.5 mg/ml
- AZOMYR orodispersible tablet 2.5 mg
- AZOMYR orodispersible tablet 5 mg
- NEOCLARITYN film-coated tablet 5 mg
- NEOCLARITYN oral solution 0.5 mg/ml
- NEOCLARITYN orodispersible tablet 2.5 mg
- NEOCLARITYN orodispersible tablet 5 mg